CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

N.H.B. Schräder

ORCID: 0000-0002-5131-7097↗

Public evidence

2 connected articles

The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.2022 · Europe PMC Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study.2021 · Europe PMC

Registered research

Connected studies

Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosanct05651607

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

N.H.B. Schräder - Medical Cannabis Research Engine